GLP-1 compounding pharmacies took center stage at digital health’s biggest conferencenews2024-10-29T13:42:26+00:00October 29th, 2024|Endpoints News|
Pfizer raises revenue guidance by $1.5B amid activist pressurenews2024-10-29T11:19:29+00:00October 29th, 2024|Endpoints News|
Corrected: Genmab lines up T cell engager pact with Revitopenews2024-10-29T11:15:59+00:00October 29th, 2024|Endpoints News|
Novartis takes $800M MorphoSys writedown mere months after closing acquisitionnews2024-10-29T11:04:41+00:00October 29th, 2024|Endpoints News|
Post-Hoc: Who will win the battle between Pfizer and Starboard?news2024-10-28T17:58:30+00:00October 28th, 2024|Endpoints News|
Bipartisan letter questions FDA’s ‘narrow’ interpretation for priority review vouchersnews2024-10-28T17:38:59+00:00October 28th, 2024|Endpoints News|
Lilly, J&J both unveil positive late-stage data in Crohn’s diseasenews2024-10-28T17:22:17+00:00October 28th, 2024|Endpoints News|
BeiGene executive reportedly under investigation in Chinanews2024-10-28T16:07:50+00:00October 28th, 2024|Endpoints News|
AbbVie makes $1.4B acquisition of Alzheimer’s biotechnews2024-10-28T14:27:08+00:00October 28th, 2024|Endpoints News|
